190 related articles for article (PubMed ID: 9140985)
1. Anti-GBM antibodies in Goodpasture syndrome; anatomy of an epitope.
Hellmark T; Segelmark M; Wieslander J
Nephrol Dial Transplant; 1997 Apr; 12(4):646-8. PubMed ID: 9140985
[No Abstract] [Full Text] [Related]
2. Goodpasture syndrome.
Kalluri R
Kidney Int; 1999 Mar; 55(3):1120-2. PubMed ID: 10027952
[No Abstract] [Full Text] [Related]
3. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease.
Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY
Nephrol Dial Transplant; 2009 Jun; 24(6):1838-44. PubMed ID: 19151145
[TBL] [Abstract][Full Text] [Related]
4. Alveolar basement membrane: molecular properties of the noncollagenous domain (hexamer) of collagen IV and its reactivity with Goodpasture autoantibodies.
Gunwar S; Bejarano PA; Kalluri R; Langeveld JP; Wisdom BJ; Noelken ME; Hudson BG
Am J Respir Cell Mol Biol; 1991 Aug; 5(2):107-12. PubMed ID: 1892641
[TBL] [Abstract][Full Text] [Related]
5. The Goodpasture antigen and basement membranes: the search must go on.
Kefalides NA
Lab Invest; 1987 Jan; 56(1):1-3. PubMed ID: 2432351
[No Abstract] [Full Text] [Related]
6. Epitope mapping of anti-glomerular basement membrane (GBM) antibodies with synthetic peptides.
Hellmark T; Brunmark C; Trojnar J; Wieslander J
Clin Exp Immunol; 1996 Sep; 105(3):504-10. PubMed ID: 8809141
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of antibodies in Goodpasture syndrome reacting with type IV collagen.
Kefalides NA; Ohno N; Wilson CB
Kidney Int; 1993 Jan; 43(1):85-93. PubMed ID: 7679459
[TBL] [Abstract][Full Text] [Related]
8. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome.
Kalluri R; Wilson CB; Weber M; Gunwar S; Chonko AM; Neilson EG; Hudson BG
J Am Soc Nephrol; 1995 Oct; 6(4):1178-85. PubMed ID: 8589284
[TBL] [Abstract][Full Text] [Related]
9. Different immunologic properties of the globular NC1 domain of collagen type IV isolated from various human basement membranes.
Weber M; Pullig O
Eur J Clin Invest; 1992 Feb; 22(2):138-46. PubMed ID: 1374033
[TBL] [Abstract][Full Text] [Related]
10. The non-collagenous domains of the alpha 3 and 4 chains of type IV collagen and their relationship to the Goodpasture antigen.
Savige JA; Gallicchio M
Clin Exp Immunol; 1991 Jun; 84(3):454-8. PubMed ID: 2044225
[TBL] [Abstract][Full Text] [Related]
11. The Goodpasture antigen.
Wieslander J
Contrib Nephrol; 1990; 80():56-67. PubMed ID: 1704301
[No Abstract] [Full Text] [Related]
12. Antigen restriction and IgG subclasses among anti-GBM autoantibodies.
Segelmark M; Butkowski R; Wieslander J
Nephrol Dial Transplant; 1990; 5(12):991-6. PubMed ID: 2128958
[TBL] [Abstract][Full Text] [Related]
13. A single autoantigen in Goodpasture's syndrome identified by a monoclonal antibody to human glomerular basement membrane.
Pusey CD; Dash A; Kershaw MJ; Morgan A; Reilly A; Rees AJ; Lockwood CM
Lab Invest; 1987 Jan; 56(1):23-31. PubMed ID: 3540450
[TBL] [Abstract][Full Text] [Related]
14. Goodpasture syndrome: molecular architecture and function of basement membrane antigen.
Hudson BG; Wieslander J; Wisdom BJ; Noelken ME
Lab Invest; 1989 Sep; 61(3):256-69. PubMed ID: 2671489
[No Abstract] [Full Text] [Related]
15. A self T cell epitope induces autoantibody response: mechanism for production of antibodies to diverse glomerular basement membrane antigens.
Wu J; Arends J; Borillo J; Zhou C; Merszei J; McMahon J; Lou YH
J Immunol; 2004 Apr; 172(7):4567-74. PubMed ID: 15034074
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of Goodpasture syndrome: a molecular perspective.
Borza DB; Neilson EG; Hudson BG
Semin Nephrol; 2003 Nov; 23(6):522-31. PubMed ID: 14631560
[TBL] [Abstract][Full Text] [Related]
17. Non-Goodpasture anti-GBM antibodies in patients with glomerulonephritis.
Bygren P; Cederholm B; Heinegård D; Wieslander J
Nephrol Dial Transplant; 1989; 4(4):254-61. PubMed ID: 2502732
[TBL] [Abstract][Full Text] [Related]
18. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility to anti-glomerular basement membrane disease and Goodpasture syndrome is linked to MHC class II genes and the emergence of T cell-mediated immunity in mice.
Kalluri R; Danoff TM; Okada H; Neilson EG
J Clin Invest; 1997 Nov; 100(9):2263-75. PubMed ID: 9410904
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the human Goodpasture antigen.
Wieslander J; Kataja M; Hudson BG
Clin Exp Immunol; 1987 Aug; 69(2):332-40. PubMed ID: 3652534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
